About
Basic Data Updated:
1 month agoJagson Pal Pharmaceuticals Limited is primarily known as a formulations company. The development and manufacturing of bulk drugs and pharmaceutical formulations are the company's main areas of expertise. Active pharmaceutical ingredients (APIs) and formulations are the key products that are developed and manufactured by the company. Some of the well-known brands under the company's name include Lycored, Maintane, Metadec, Metabol, Doxypal DR, Parvon, and Indocap SR. The company offers a wide range of APIs such as allylestrenol, dextropropoxyphene HCl, dextropropoxyphene napsylate, disulfiram, thiopental sodium, thiopental acid, tolnaftate, metformin HCl BP, USP, EP, and sildenafil citrate. According to its credit rating report, JPPL currently operates one manufacturing facility in Faridabad, Haryana. The company was established in 1978 and is headquartered in New Delhi.
Industry
Company Details
- Location
South Delhi, Delhi, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | L74899DL1978PLC009181 |
| Company No. | 009181 |
| Stock Symbol | BSE : 507789 NSE : JAGSNPHARM |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 17 Aug 1978 |
| Date of AGM | 31 Aug 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Listed |
| ROC Code | Roc Delhi |
Financials of Jagson Pal Pharmaceuticals Limited.
Jagson Pal Pharmaceuticals Limited., for the financial year ended 2023, experienced modest growth in revenue, with a 5.67% increase. The company also saw a substantial improvement in profitability, with a 36.42% increase in profit. The company's net worth Soared by an impressive increase of 21.42%.
Corporate Structure
Unlock access to Jagson Pal Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Jagson Pal Pharmaceuticals Limited.
Unlock and access historical data on people associated with Jagson Pal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
MG
Manish Gupta
Managing DirectorAppointment Date: 16-Jul-2022
Status: Current
AL
Ashish Lakhotia CFOAppointment Date: 20-Feb-2024
Status: Current
AJ
Abhishek Joshi Company SecretaryAppointment Date: 13-Feb-2023
Status: Current
Board Members(5)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab & Sind Bank Creation Date: 26 Oct 2010 | ₹6.70 Cr | Satisfied |
Punjab & Sind Bank Creation Date: 26 Oct 2010 | ₹3.00 M | Satisfied |
Punjab & Sind Bank Creation Date: 26 Oct 2010 | ₹31.90 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jagson Pal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagson Pal Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
55 years 11 months 
Recent activity within the organization
Director Appointment
Ashish Lakhotia was appointed as a Cfo was appointed as a Cfo on 20 Feb 2024 & has been associated with this company since 3 months 2 days .
20 Feb 2024Annual General Meeting
Jagson Pal Pharmaceuticals Limited. last Annual general meeting of members was held on 31 Aug 2023 as per latest MCA records.
31 Aug 2023Balance Sheet
Jagson Pal Pharmaceuticals Limited. has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
31 Mar 2023Director Appointment
Manish Gupta was appointed as a Managing Director was appointed as a Managing Director on 16 Jul 2022 & has been associated with this company since 1 year 10 months .
16 Jul 2022Director Appointment
Radhika Carlton Pereira was appointed as a Director was appointed as a Director on 29 Jun 2022 & has been associated with this company since 1 year 10 months .
29 Jun 2022
Recent News, Updates & Announcement
Jagsonpal Pharmaceuticals director Surinder Kumar Goyal resigns.Jagsonpal Pharmaceuticals Ltd has informed BSE that Dr Surinder Kumar Goyal Director has resigned from Directorship of the Company wef February 14 2017 his resignation has been approved by the Board of Directors in their meeting held on February 14 2017 Copy of resignation ampamp resolution is enclosed.
Moneycontrol 15 Feb 2017
- Jagsonpal Pharmaceuticals Outcome of board meeting.
Jagsonpal Pharmaceuticals Ltd has informed BSE about Outcome of Board Meeting held on February 14 2017.
Moneycontrol 14 Feb 2017
Frequently asked questions
What is the Incorporation or founding date of Jagson Pal Pharmaceuticals Limited.?
